 About 2% of people with scleroderma are positive for more than one disease-associated antibody that targets tissues, causing damaging inflammation, according to a new study. Results suggest that certain antibody combinations may be associated with distinct clinical features. Comments are closed.
|
Scleroderma Association of Queensland
ABN 91 905 099 795
©Scleroderma Association of Queensland. All rights reserved. Website by Grey and Grey.